TR200002848T2 - Ksantan zamkı içeren, jelleşen oftalmik bileşimler. - Google Patents

Ksantan zamkı içeren, jelleşen oftalmik bileşimler.

Info

Publication number
TR200002848T2
TR200002848T2 TR2000/02848T TR200002848T TR200002848T2 TR 200002848 T2 TR200002848 T2 TR 200002848T2 TR 2000/02848 T TR2000/02848 T TR 2000/02848T TR 200002848 T TR200002848 T TR 200002848T TR 200002848 T2 TR200002848 T2 TR 200002848T2
Authority
TR
Turkey
Prior art keywords
xanthan gum
compositions containing
ophthalmic compositions
containing xanthan
gel ophthalmic
Prior art date
Application number
TR2000/02848T
Other languages
English (en)
Inventor
Bawa Rajan
E.Hall Rex
P. Kabra Bhagwati
E.Teague James
Original Assignee
Alcon Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories, Inc. filed Critical Alcon Laboratories, Inc.
Publication of TR200002848T2 publication Critical patent/TR200002848T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bir sivi halinde uygulanabilen ve gözle temas ettiginde jellesen oftalmik ilaç verici vasitalar açiklanmistir. Vasitalar, ksantan zamki içerirler.
TR2000/02848T 1998-04-07 1999-03-26 Ksantan zamkı içeren, jelleşen oftalmik bileşimler. TR200002848T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8100498P 1998-04-07 1998-04-07

Publications (1)

Publication Number Publication Date
TR200002848T2 true TR200002848T2 (tr) 2001-02-21

Family

ID=22161189

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02848T TR200002848T2 (tr) 1998-04-07 1999-03-26 Ksantan zamkı içeren, jelleşen oftalmik bileşimler.

Country Status (19)

Country Link
EP (1) EP1069913B1 (tr)
JP (1) JP4545927B2 (tr)
KR (1) KR100598722B1 (tr)
CN (1) CN1133466C (tr)
AR (1) AR016460A1 (tr)
AT (1) ATE245451T1 (tr)
AU (1) AU740586B2 (tr)
BR (1) BR9910113A (tr)
CA (1) CA2322579C (tr)
DE (1) DE69909768T2 (tr)
DK (1) DK1069913T3 (tr)
ES (1) ES2203103T3 (tr)
HK (1) HK1031335A1 (tr)
NZ (1) NZ506921A (tr)
PT (1) PT1069913E (tr)
TR (1) TR200002848T2 (tr)
TW (1) TWI262797B (tr)
WO (1) WO1999051273A1 (tr)
ZA (1) ZA200004413B (tr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
DE20022450U1 (de) * 1999-01-19 2002-01-17 Mann Gerhard Chem Pharm Fab Künstliche Tränenflüssigkeit in Gelform
CN1384745A (zh) * 1999-11-01 2002-12-11 爱尔康公司 含有一种氟喹诺酮抗生素和黄原酸胶的药物组合物
EP1250133B1 (en) * 2000-01-25 2005-03-30 Alcon Inc. Ophthalmic anti-allergy compositions suitable for use with contact lenses
BR0109192A (pt) * 2000-03-16 2003-05-27 Sucampo Ag Tratamento de hipertensão ocular e glaucoma.
US6458836B1 (en) 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma
JP4927298B2 (ja) 2000-07-14 2012-05-09 アラーガン、インコーポレイテッド α−２−アドレナリンアゴニスト成分を含有する組成物
PL361027A1 (en) 2000-07-14 2004-09-20 Allergan,Inc. Compositions containing therapeutically active components having enhanced solubility
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension
CN1218689C (zh) 2000-07-28 2005-09-14 爱尔康公司 包含妥布霉素和黄原胶的药物组合物
CA2428799A1 (en) * 2000-11-16 2002-05-23 Alcon Manufacturing, Ltd. Combination therapy for lowering and controlling intraocular pressure
WO2002049611A2 (en) 2000-12-20 2002-06-27 Alcon, Inc. Ophthalmic lubricating solution adapted for use in lasik surgery
US6878694B2 (en) 2000-12-20 2005-04-12 Alcon, Inc. Ophthalmic irrigating solution adapted for use in lasik surgery
US7084130B2 (en) 2001-12-11 2006-08-01 Alcon, Inc. Intraocular irrigating solution having improved flow characteristics
US7169755B2 (en) 2000-12-20 2007-01-30 Alcon, Inc. Solution for removing cataracts via liquefracture
JP2005519978A (ja) * 2002-03-28 2005-07-07 スキャンポ・アーゲー 高眼圧症および緑内障の処置方法
US7030149B2 (en) * 2002-04-19 2006-04-18 Allergan, Inc. Combination of brimonidine timolol for topical ophthalmic use
WO2005018646A1 (ja) * 2003-08-21 2005-03-03 Sucampo Ag 眼科用組成物
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
EP1797888A4 (en) 2004-09-28 2009-12-16 Senju Pharma Co OPHTHALMIC COMPOSITION CONTAINING XANTHAN GUM AND AN AMINO ACID
WO2007032997A1 (en) * 2005-09-13 2007-03-22 Bausch & Lomb Incorporated Ophthalmic formulation containing loteprednol etabonate for treatment of dry eye
KR101381035B1 (ko) 2006-03-23 2014-04-04 센주 세이야꾸 가부시키가이샤 잔탄검 및 글루코스를 포함하는 안약 조성물
CA2659687A1 (en) 2006-07-31 2008-02-07 Senju Pharmaceutical Co., Ltd. Aqueous liquid preparation containing amide compound
CA2666440A1 (en) 2006-10-12 2008-04-17 Kyorin Pharmaceutical Co., Ltd. Aqueous liquid preparation having improved intraocular gatifloxacin penetration
TWI544934B (zh) 2008-06-09 2016-08-11 愛爾康研究有限公司 含有氟喹諾酮抗生素藥物之經改良藥學組成物
DE102010009475B4 (de) 2010-02-26 2011-11-24 F. Holzer Gmbh Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates
US20130267591A1 (en) * 2010-05-07 2013-10-10 Sun Pharma Advanced Research Company Limited Novel ophthalmic compositions
JP5713791B2 (ja) * 2010-05-12 2015-05-07 テイカ製薬株式会社 眼科用剤
BR112012033052A2 (pt) * 2010-06-23 2019-09-24 Alcon Res Ltd suspensões oftálmicas tópicas contendo tobramicin e dexametasona
WO2012026609A1 (ja) * 2010-08-27 2012-03-01 わかもと製薬株式会社 点眼用水性組成物
WO2016061145A1 (en) 2014-10-13 2016-04-21 Symic Biomedical, Inc. Synthetic proteoglycans for preventing tissue adhesion
US20170368192A1 (en) 2014-10-13 2017-12-28 Symic Ip, Llc Luminal vessel coating for arteriovenous fistula
WO2016065083A1 (en) 2014-10-21 2016-04-28 Symic Biomedical, Inc. Peptidoglycans comprising collagen-binding peptides for treating gastroesophageal injury
CN104825386A (zh) * 2015-05-25 2015-08-12 湖北汇瑞药业股份有限公司 一种表皮麻醉凝胶及其制备方法
WO2017066349A1 (en) 2015-10-13 2017-04-20 Symic Ip, Llc Ve-cadherin binding bioconjugate
KR101770324B1 (ko) 2016-11-09 2017-08-22 주식회사태준제약 안압 강하용 점안 조성물
CN109722347B (zh) * 2019-01-03 2020-12-29 山东省药学科学院 一种含有黄原胶的保湿润滑组合物及其应用
KR102678138B1 (ko) * 2022-09-29 2024-06-25 주식회사태준제약 브리모니딘을 포함하는 안과용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4814160A (en) * 1988-03-01 1989-03-21 Colgate-Palmolive Company Non-bleeding striped dentifrice
US6093420A (en) * 1996-07-08 2000-07-25 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs

Also Published As

Publication number Publication date
DK1069913T3 (da) 2003-11-17
AU740586B2 (en) 2001-11-08
CA2322579C (en) 2001-08-28
NZ506921A (en) 2002-02-01
WO1999051273A1 (en) 1999-10-14
CN1133466C (zh) 2004-01-07
DE69909768D1 (de) 2003-08-28
HK1031335A1 (en) 2001-06-15
PT1069913E (pt) 2003-11-28
EP1069913A1 (en) 2001-01-24
CA2322579A1 (en) 1999-10-14
ATE245451T1 (de) 2003-08-15
BR9910113A (pt) 2000-12-26
AR016460A1 (es) 2001-07-04
AU3194799A (en) 1999-10-25
KR100598722B1 (ko) 2006-07-11
ZA200004413B (en) 2001-05-22
ES2203103T3 (es) 2004-04-01
JP4545927B2 (ja) 2010-09-15
TWI262797B (en) 2006-10-01
DE69909768T2 (de) 2004-06-17
CN1295483A (zh) 2001-05-16
JP2002510654A (ja) 2002-04-09
EP1069913B1 (en) 2003-07-23
KR20010041473A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
TR200002848T2 (tr) Ksantan zamkı içeren, jelleşen oftalmik bileşimler.
DK0725628T3 (da) Termisk geldannende lægemiddelindgivelsesvehikler indeholdende celluloseethere
MX170239B (es) Aplicador topico para liquido
DE69514234T2 (de) Oberflächenlokalisierte expression von enzymen in gengesteuerter prodrugtherapie
DE69804812T2 (de) Behälter für kontaktlinsen
BR0315583A (pt) Cobertura semi-hidrofóbica para um produto absorvente
ES278992U (es) Un dispositivo para la distribucion de vapores de tratamiento del aire
MY133168A (en) Emulsible polyolefin wax
CO5011082A1 (es) Formulacion medicamentosa con liberacion controlada de sus- tancia activa
AT349788B (de) Kontaktlinsen, medizinische, in kontakt mit koerperfluessigkeit stehende prothesen u.dgl.
ATE144701T1 (de) Verwendung einer kombination aus gelbindender polysacchariden und fein verteilten arzneimittelträgern in ophtalmischen topischen zusammensetzungen
AR023322A1 (es) Cierrapuertas
YU45591A (sh) Novi retinoidi
BR0314787A (pt) Forma de dosagem de liberação modificada
CO5070588A1 (es) Comprimidos de ciclofosfamida recubiertos con pelicula
PT942702E (pt) Dispositivo de aprovisionamento de mechas medicinais
AR245587A1 (es) Dispositivo para administrar medicamentos veterinarios.
DE69516877D1 (de) Bausteinartiges lager-und anzeigeelement
ES2100206T3 (es) Aparato de comunicacion.
ATE415955T1 (de) Aufladbares hautpflaster
AR029965A1 (es) Composiciones farmaceuticas con contenido de tobramicina y goma de xantano
TW200503797A (en) Enclosed applicator
Rimbaud et al. Rimbaud
ES2156820A1 (es) Caramelo refrescante.
Moeller Boyd and Levy," Promotion: A Behavioral View"(Book Review)